期刊文献+

放射性粒子剂量学特性研究进展 被引量:1

原文传递
导出
摘要 放射性粒子植入作为早期低危前列腺癌根治性治疗手段之一,其疗效与根治手术或外照射放疗相当,但其创伤和不良反应更小、治疗时间更短、对设备和场地要求更低,其优势被越来越多的患者和医生所青昧。剂量分布是影响粒子植入疗效最直接、最重要的因素,类似于外科手术的切除程度和范围直接影响肿瘤控制效果和不良反应。
作者 赵楠 杨瑞杰
出处 《中华放射医学与防护杂志》 CAS CSCD 北大核心 2015年第10期797-800,共4页 Chinese Journal of Radiological Medicine and Protection
基金 国家自然科学基金(81372420)
  • 相关文献

参考文献45

  • 1Zelefsky M J, Kuban DA, Levy LB, at al. Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation[ J]. Int J Radiat Oneol Biol Phys, 2007, 67(2): 327-333.
  • 2Willtamson JF. Braehytherapy technology and physics practice since 1950: a half-century of progress[ J]. Phys Med Biol, 2006, 51 (13) : R303-R32.
  • 3杨瑞杰,王俊杰,杨瑞学.放射性粒子植入计划系统剂量计算准确性验证[J].中华放射医学与防护杂志,2011,31(4):493-495. 被引量:3
  • 4杨瑞杰,姜玉良,李金娜,王俊杰.复发性直肠癌CT引导^(125)I粒子植入的剂量学验证[J].中国肿瘤,2009,18(10):848-850. 被引量:17
  • 5Rivard M J, Coursey BM, Dewerd LA, et el. Update of AAPM Task Group No 43 report: a revised AAPM protocol for breehytherapy dose calculations[ J]. Med Phys, 2004, 31 (3): 633 -674.
  • 6Nath R, Anderson LL, Luxton G, et el. Dosimetry of interstitial brachytherapy sources, recommendations of the AAPM Radiation Therapy Committee Task Group No 43J]. Mad Phys, 1995, 22 (2) : 209-234.
  • 7Tang K, Cui H, Zhu H, et al. Study of a new Lif: Mg, Cu, P formulation with enhanced thermal stability and a lower residual TL signa|[ J]. Radiat Meas, 2007,42(1 ) 24-28.
  • 8Patel NS, Chiu-Tsao ST, Williamson JF, et al. Thermoluminescent dosimetry of the SymmetraTM 12s I model I2. $06 interstitial brachytherapy seed [ J]. Med Phys, 2001, 28 (8) : 1761-1769.
  • 9Moutsatsos A, Pantelis E, Papagiannls P, etal. Experimental determination of the Task Group-43 dosimetrlc parameters of the new I25. $17 plus 12s I brachytherapy source[ J ]. Brachytherapy, 2014, 13(6) . 618-626.
  • 10Chen Z, Bongiorni P, Nath B. Experimental characterization of the dosimetric properties of a newly designed I-Seed model AgX100 12si interstitial brachytherapy source [ J ]. Braehytherapy, 2012, 11 ( 6 )., 476-482.

二级参考文献14

  • 1张福君,吴沛宏,赵明,黄金华,范卫君,顾仰葵,刘健,张亮,卢鸣剑.CT导引下^(125)I粒子植入治疗胰腺癌[J].中华医学杂志,2006,86(4):223-227. 被引量:120
  • 2王俊杰,袁惠书,刘江平,姜伟娟,李金娜,姜玉良,田素青.CT引导放射性^(125)Ⅰ粒子组织间植入治疗复发直肠癌的疗效观察[J].中华放射肿瘤学杂志,2006,15(4):319-322. 被引量:37
  • 3Nath R, Anderson LL, Luxton G, et al. Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. Med Phys, 1995, 22 (2) :209-234.
  • 4Rivard M J, Coursey BM, DeWerd LA, et al. Update of AAPM Task Group No. 43 Report: a revised AAPM protocol for brachytherapy dose calculations. Med Phys, 2004, 31 ( 3 ) : 633-674.
  • 5IAEA. Commissioning and quality assurance of computerized planning systems for radiation treatment of cancer. IAEA Technical Reports Series No. 430. Vienna:IAEA, 2004.
  • 6DeWerd LA, Huq MS, Das IJ, ct al. Procedures for establishing and maintaining consistent air-kerma strength standards for low- energy, photon-emitting brachytherapy sources: recommendations of the Calibration Laboratory Accreditation Subcommittee of the American Association of Physicists in Medicine. Med Phys, 2004, 31(3) :675-.681.
  • 7Butler WM, Bice WS Jr, DeWerd LA, et al. Third-party brachytherapy source calibrations and physicist responsibilities: report of the AAPM Low Energy Brachytherapy Source Calibration Working Group. Med Phys, 2008, 35 (9) :3860-3865.
  • 8Fraass B, Doppke K, Hunt M, et al. American Association of Physicists in Medicine Radiation Therapy Committee Task Group 53 : quality assurance for clinical radiotherapy treatment planning. Med Phys, 1998, 25 (10) : 1773-1829.
  • 9Williamson JF. Brachytherapy technology and ph- ysics practice since 1950 : a half-century of progress [J]. Phys Med Biol, 2006,51:R303-R325.
  • 10全国核能标准化技术委员会.GB/T12162.12000idtISO40371:1996.用于校准计量仪和剂量率仪及确定其能量响应的X和γ参考辐射第一部分:辐射特性及产生方法[S].北京:中国标准出版社,2000.

共引文献18

同被引文献9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部